Bridge to Life Reports First U.S. Commercial Adoption of VitaSmart™ HOPE System by Leading Transplant Center Following FDA Clearance, Reflecting Early Physician Confidence DULUTH, Ga., March 24, 2026 — Bridge to
Bridge to Life™ Secures FDA De Novo Clearance for VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System, the First Ever U.S. Approval for Cold Machine Perfusion in Liver Transplant Preservation VitaSmart Commercial Launch Expected
Solvita Partners with Taylor’s Gift to Provide Grief Support for Donor Families Kettering, OH – October 31, 2025 – Solvita, a leading nonprofit organization serving communities across the globe is the
Bridge to Life CEO Don Webber Shares HOPE Breakthrough with Transplant Community at WTC 2025 To the Organ Transplantation Community, What an incredible week it was for Bridge to Life at the World
FOR IMMEDIATE RELEASE First-Ever Multicenter Study of Hypothermic Oxygenated Perfusion (HOPE) with VitaSmart™ in Pediatric Liver Transplants Confirms Safety and Favorable Outcomes Groundbreaking: The first multicenter study in any machine perfusion device,
USA – At the annual Association for Multicultural Affairs in Transplantation (AMAT) conference, Erica Randall, Community Partnerships and Events Manager at Network for Hope, shared her mission to mobilize student
FOR IMMEDIATE RELEASE New Data Analyses from Groundbreaking Pivotal Bridge to HOPE Clinical Trial Demonstrate Statistically Significant Clinical, Economic and Immunomodulatory Advantages in Liver Transplantation Presentations showcased at World Transplant Congress in
Abstracts to highlight hypothermic oxygenated perfusion (HOPE) in liver transplants, including pediatric patients Chicago, May 15, 2025 Bridge to Life™ Ltd., a leader in organ preservation solutions and perfusion technology, today announced the
FOR IMMEDIATE RELEASE First-Ever Comparative Study of Hypothermic Oxygenated Machine Perfusion (HOPE) with Normothermic Machine Perfusion (NMP) in Liver Transplantation Shows Better Outcomes With HOPE New data presented during Plenary Session at
What is silent rejection? Also known as subclinical acute rejection, or subAR, silent rejection leads to significant complications if left undetected or untreated. It is also the earliest form of rejection
Financial Toxicity and Heart Transplants: A Growing Concern By Denise Redeker- Heartfelt Help Foundation For heart transplant patients, the gift of life often comes with a hefty personal price tag. Financial toxicity,
The Contigo Foundation has pledged $450,000 to support student-driven organ, eye, and tissue donation advocacy, reinforcing its longstanding commitment to saving lives through education and donor registration. This pledge, which
